Dr. Reddys Laboratories Ltd.

Dr. Reddys Laboratories is currently trading at Rs. 2438.00, up by 26.30 points or 1.09% from its previous closing of Rs. 2411.70 on the BSE.

The scrip opened at Rs. 2411.70 and has touched a high and low of Rs. 2464.00 and Rs. 2382.05 respectively. So far 29811 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 3689.00 on 20-Jul-2016 and a 52 week low of Rs. 2382.05 on 25-May-2017.

Last one week high and low of the scrip stood at Rs. 2685.00 and Rs. 2382.05 respectively. The current market cap of the company is Rs. 40494.02 crore.

The promoters holding in the company stood at 26.79%, while Institutions and Non-Institutions held 42.95% and 13.87% respectively.

US Food and Drug Administration (USFDA) has completed audit of Dr. Reddy’s Laboratories’ Formulations Srikakulum Plant (SEZ) Unit II, Andhra Pradesh on May 25, 2017 with zero observations.

Recently, USFDA had completed audit of the company’s Formulations Manufacturing Plant - 3 at Bachupally, Hyderabad on April 28, 2017. The company had been issued a Form 483 with 11 observations.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.